Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology
Link
https://link.springer.com/content/pdf/10.1007/s00345-022-03958-9.pdf
Reference29 articles.
1. Gontero P, Mostafid AH, Palou J et al (2019) European Association of Urology Guidelines on Non- muscle-invasive bladder cancer (TaT1 and carcinoma in situ)2019 update. Eur Urol 76(5):639–657. https://doi.org/10.1016/j.eururo.2019.08.016
2. Balakrishnan AS, Washington SL, Meng MV, Porten SP (2019) Determinants of guideline-based treatment in patients with cT1 bladder cancer. Clin Genitourin Cancer 17:e461–e471. https://doi.org/10.1016/j.clgc.2019.01.007
3. Patriarca C, Hurle R, Moschini M et al (2016) Usefulness of pT1 substaging in papillary urothelial bladder carcinoma. Diagn Pathol. https://doi.org/10.1186/s13000-016-0466-6
4. Colombo R, Hurle R, Moschini M et al (2018) Feasibility and clinical roles of different substaging systems at first and second transurethral resection in patients with T1 high-grade bladder cancer. Eur Urol Focus 4:87–93. https://doi.org/10.1016/j.euf.2016.06.004
5. Horwich A, Babjuk M, Bellmunt J et al (2019) EAU–ESMO consensus statements on the management of advanced and variant bladder cancer—an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees. Ann Oncol 30:1697–1727. https://doi.org/10.1093/annonc/mdz296
Cited by 11 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative efficacy of Bacillus Calmette–Guérin instillation and radical cystectomy treatments for high-risk non-muscle-invasive urothelial cancer classified as high-grade T1 in initial and repeat transurethral resection of bladder tumor;Frontiers in Oncology;2024-06-18
2. Clinical efficacy analysis of partial cystectomy and radical cystectomy in the treatment of muscle-invasive sarcomatoid carcinoma of the urinary bladder;Frontiers in Oncology;2024-02-02
3. Metastatic Squamous Cell Carcinoma of the Urinary Bladder: Urgent Call for New Therapies;Urologia Internationalis;2023-12-21
4. Cancer-Specific Survival of Patients with Non-Muscle-Invasive Bladder Cancer: A Population-Based Analysis;Annals of Surgical Oncology;2023-08-14
5. Low-dose or -number of BCG in non-muscle invasive bladder cancer: updated systematic review and meta-analysis;Immunotherapy;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3